By Benjamin Chiou
Date: Monday 13 Oct 2025
(Sharecast News) - IP Group said it is "encouraged" by the results of a recent clinical trial of a Metsara obesity drug, which could result in future sustainable royalties if approved by regulators.
| Transaction in Own Shares | 04-Nov-2025 | 07:00 | RNS | 
| Total Voting Rights | 31-Oct-2025 | 17:25 | RNS | 
| Transaction in Own Shares | 31-Oct-2025 | 17:19 | RNS | 
| Transaction in Own Shares | 31-Oct-2025 | 07:00 | RNS | 
| Transaction in Own Shares | 29-Oct-2025 | 17:27 | RNS | 
| Non-stick gum firm steps ahead | 08-May-2008 | Telegraph | 
| Biotech firms hail biggest venture capital fund | 31-Jan-2007 | Guardian | 
| Change of heart | 16-Oct-2006 | The Scotsman | 
| Couple to cash in £120m from retail empire that ... | 22-Sep-2006 | The Independent | 
| Need to know: Global Business Briefing | 09-Sep-2006 | Times | 
| Investment Column:IP Group | 04-May-2011 | The Independent | 
| The Investment Column:IP Group | 29-Aug-2008 | The Independent | 
| Questor: IP Group | 11-May-2008 | Sunday Telegraph | 
| Market ends down after fluctuation | 08-Jun-2007 | Guardian | 
| The Week Ahead: Investors seek crumbs of comfort... | 05-Mar-2007 | The Independent | 
No recent information was found.
| Currency | UK Pounds | 
| Share Price | 60.20p | 
| Change Today | -0.70p | 
| % Change | -1.15 % | 
| 52 Week High | 61.60 | 
| 52 Week Low | 34.80 | 
| Volume | 130,357 | 
| Shares Issued | 887.74m | 
| Market Cap | £534.42m | 
| RiskGrade | 192 | 
| Value | 
		 | 
		
|---|
| Price Trend | 
		 | 
		
|---|
| Income | ![]()  | 
				
|---|
| Growth | ![]()  | 
				
|---|
| Strong Buy | 2 | 
| Buy | 0 | 
| Neutral | 0 | 
| Sell | 0 | 
| Strong Sell | 0 | 
| Total | 2 | 

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 10-Aug-23 | 25-May-23 | 
| Paid | 04-Sep-23 | 22-Jun-23 | 
| Amount | 0.51p | 0.76p | 
| Time | Volume / Share Price | 
| 08:24 | 8,412 @ 60.20p | 
| 08:21 | 2,684 @ 60.20p | 
| 08:21 | 4,500 @ 60.20p | 
| 08:21 | 6,400 @ 60.20p | 
| 08:21 | 2,699 @ 60.20p | 
You are here: research